600211 西藏药业
已收盘 07-29 15:00:00
资讯
新帖
简况
北向资金7月25日净买入西藏药业12.95万股 连续5日增持
自选股智能写手 · 07-26
北向资金7月25日净买入西藏药业12.95万股 连续5日增持
西藏药业07月25日主力资金流出187万元 连续5日减仓
自选股智能写手 · 07-25
西藏药业07月25日主力资金流出187万元 连续5日减仓
北向资金7月23日净买入西藏药业5.43万股 连续3日增持
自选股智能写手 · 07-24
北向资金7月23日净买入西藏药业5.43万股 连续3日增持
西藏药业07月18日获主力加仓897万元 环比增加2035.71%
自选股智能写手 · 07-18
西藏药业07月18日获主力加仓897万元 环比增加2035.71%
北向资金7月16日净买入西藏药业4.23万股 连续3日增持
自选股智能写手 · 07-17
北向资金7月16日净买入西藏药业4.23万股 连续3日增持
西藏药业:公司主力产品新活素暂时没有开展海外销售的具体计划,但产品依姆多在海外销售
每日经济新闻 · 07-11
西藏药业:公司主力产品新活素暂时没有开展海外销售的具体计划,但产品依姆多在海外销售
西藏药业07月11日获主力加仓721万元 环比增加390.48%
自选股智能写手 · 07-11
西藏药业07月11日获主力加仓721万元 环比增加390.48%
西藏药业: 公司目前暂未收到控股股东回购股票计划。
证券之星 · 07-10
西藏药业: 公司目前暂未收到控股股东回购股票计划。
西藏药业(600211.SH):新活素新产线预计下半年通过注册审批后投入正式生产
格隆汇资讯 · 07-10
西藏药业(600211.SH):新活素新产线预计下半年通过注册审批后投入正式生产
【机构调研记录】鹏华基金调研西藏药业、和而泰
证券之星 · 07-10
【机构调研记录】鹏华基金调研西藏药业、和而泰
【机构调研记录】湘财基金调研西藏药业
证券之星 · 07-10
【机构调研记录】湘财基金调研西藏药业
【机构调研记录】汇添富基金调研西藏药业、北方国际等3只个股(附名单)
证券之星 · 07-10
【机构调研记录】汇添富基金调研西藏药业、北方国际等3只个股(附名单)
【机构调研记录】中银基金调研西藏药业、荣昌生物
证券之星 · 07-10
【机构调研记录】中银基金调研西藏药业、荣昌生物
【机构调研记录】中航基金调研西藏药业
证券之星 · 07-10
【机构调研记录】中航基金调研西藏药业
西藏药业:雪山金罗汉止痛涂膜剂规格有20ml、30ml、60ml,其中20ml、30ml为新包装
每日经济新闻 · 07-09
西藏药业:雪山金罗汉止痛涂膜剂规格有20ml、30ml、60ml,其中20ml、30ml为新包装
西藏药业07月09日主力资金流出43万元 连续5日减仓
自选股智能写手 · 07-09
西藏药业07月09日主力资金流出43万元 连续5日减仓
西藏药业07月05日主力资金流出109万元 连续3日减仓
自选股智能写手 · 07-05
西藏药业07月05日主力资金流出109万元 连续3日减仓
西藏板块盘中跳水,西藏药业跌0.47%
自选股智能写手 · 07-05
西藏板块盘中跳水,西藏药业跌0.47%
脑科学(脑机接口)概念盘中跳水,西藏药业跌0.12%
自选股智能写手 · 07-04
脑科学(脑机接口)概念盘中跳水,西藏药业跌0.12%
西藏药业:公司会根据中药的原材料价格、生产成本上涨等实际情况进行相应调整
证券之星 · 07-02
西藏药业:公司会根据中药的原材料价格、生产成本上涨等实际情况进行相应调整
暂无数据
公司概况
公司名称:
西藏诺迪康药业股份有限公司
所属行业:
医药制造业
上市日期:
1999-07-21
主营业务:
西藏诺迪康药业股份有限公司主要业务是生产、销售胶囊剂、生物制剂、颗粒剂、涂膜剂等。公司主要产品涉及心脑血管、肝胆、扭挫伤及风湿、类风湿、感冒等领域,代表品种有新活素、依姆多、诺迪康、十味蒂达胶囊、雪山金罗汉止痛涂膜剂、小儿双清颗粒等。公司先后荣获“金牛最具投资价值奖”“生物医药最具成长上市公司”“中国中药工业百强企业TOP100”“中国医药工业百强企业”“西藏自治区专精特新中小企业”“西藏自治区民营企业20强”等多项荣誉。西藏自治区药品监督管理局向我公司授予“药品标准科研基地”。
发行价格:
6.00
{"stockData":{"symbol":"600211","market":"SH","secType":"STK","nameCN":"西藏药业","latestPrice":31.76,"timestamp":1722236400000,"preClose":32.42,"halted":0,"volume":1473963,"delay":0,"floatShares":322000000,"shares":322000000,"eps":2.5151,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.66,"latestTime":"07-29 15:00:00","open":32.37,"high":32.37,"low":31.76,"amount":47049000,"amplitude":0.0188,"askPrice":31.78,"askSize":6,"bidPrice":31.76,"bidSize":5,"shortable":0,"etf":0,"ttmEps":2.5151,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1722303000000},"adr":0,"adjPreClose":32.42,"symbolType":"stock","openAndCloseTimeList":[[1722216600000,1722223800000],[1722229200000,1722236400000]],"highLimit":35.66,"lowLimit":29.18,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":322319196,"pbRate":2.8,"roa":"--","roe":"8.94%","epsLYR":3.23,"committee":-0.334728,"marketValue":10237000000,"floatMarketCap":10237000000,"peRate":12.627729,"changeRate":-0.0204,"turnoverRate":0.0046,"status":1},"requestUrl":"/m/hq/s/600211/tweets","defaultTab":"tweets","newsList":[{"id":"2454355699","title":"北向资金7月25日净买入西藏药业12.95万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2454355699","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454355699?lang=zh_cn&edition=full","pubTime":"2024-07-26 09:30","pubTimestamp":1721957410,"startTime":"0","endTime":"0","summary":"7月25日, 北向资金增持西藏药业12.95万股,连续5日增持。截止当日收盘,沪股通共持有西藏药业273.72万股,占流通股0.84%。沪股通增持金额前五个股分别为紫金矿业、中国船舶、洛阳钼业、中金黄金、海尔智家。西藏药业近5个交易日下跌5.24%,沪股通累计增持39.77万股;近20个交易日下跌0.65%,沪股通累计增持2.97万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407260930459eeb8640&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407260930459eeb8640&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600211","BK0239","BK0033"],"gpt_icon":0},{"id":"2454846608","title":"西藏药业07月25日主力资金流出187万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2454846608","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454846608?lang=zh_cn&edition=full","pubTime":"2024-07-25 15:17","pubTimestamp":1721891861,"startTime":"0","endTime":"0","summary":"07月25日, 西藏药业股价涨0.59%,报收32.21元,成交金额4482万元,换手率0.43%,振幅2.75%,量比0.64。西藏药业今日主力资金净流出187万元,连续5日净流出,上一交易日主力净流出936万元,今日环比减少80.02%。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为38.46%,平均跌幅为1.00%。该股近5个交易日下跌5.24%,主力资金累计净流出3495万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出2745万元,其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072515200395592511&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072515200395592511&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","600211","BK0033"],"gpt_icon":0},{"id":"2453014875","title":"北向资金7月23日净买入西藏药业5.43万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2453014875","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453014875?lang=zh_cn&edition=full","pubTime":"2024-07-24 09:30","pubTimestamp":1721784608,"startTime":"0","endTime":"0","summary":"7月23日, 北向资金增持西藏药业5.43万股,连续3日增持。截止当日收盘,沪股通共持有西藏药业255.66万股,占流通股0.79%。西藏药业近5个交易日下跌1.84%,沪股通累计增持9.65万股;近20个交易日下跌1.84%,沪股通累计减持21.90万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407240930379ee41b74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407240930379ee41b74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0033","BK0239","600211"],"gpt_icon":0},{"id":"2452717357","title":"西藏药业07月18日获主力加仓897万元 环比增加2035.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452717357","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452717357?lang=zh_cn&edition=full","pubTime":"2024-07-18 15:17","pubTimestamp":1721287051,"startTime":"0","endTime":"0","summary":"07月18日, 西藏药业股价涨1.28%,报收33.99元,成交金额9361万元,换手率0.86%,振幅2.62%,量比1.42。西藏药业今日主力资金净流入897万元,上一交易日主力净流入42万元,今日环比增加2035.71%。该股近5个交易日上涨2.13%,主力资金累计净流入597万元;近20日主力资金累计净流出259万元,其中净流出天数为13日。该行业中净流入前三个股分别为双鹭药业、智飞生物、西藏药业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407181519399f628033&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407181519399f628033&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0033","BK0239","600211"],"gpt_icon":0},{"id":"2452971540","title":"北向资金7月16日净买入西藏药业4.23万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2452971540","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452971540?lang=zh_cn&edition=full","pubTime":"2024-07-17 09:30","pubTimestamp":1721179809,"startTime":"0","endTime":"0","summary":"7月16日, 北向资金增持西藏药业4.23万股,连续3日增持。截止当日收盘,沪股通共持有西藏药业246.02万股,占流通股0.76%。沪股通增持金额前五个股分别为寒武纪-U、巨化股份、XD中国核、澜起科技、海光信息。西藏药业近5个交易日上涨3.66%,沪股通累计增持4.55万股;近20个交易日下跌7.21%,沪股通累计减持2.90万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170930449f5a0ca9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170930449f5a0ca9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","600211","BK0033"],"gpt_icon":0},{"id":"2450343613","title":"西藏药业:公司主力产品新活素暂时没有开展海外销售的具体计划,但产品依姆多在海外销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2450343613","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450343613?lang=zh_cn&edition=full","pubTime":"2024-07-11 17:42","pubTimestamp":1720690976,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:公司的主力产品有没有向海外推广的潜力和计划?海外是否有相同疗效的产品?西藏药业(600211.SH)7月11日在投资者互动平台表示,公司主力产品新活素暂时没有开展海外销售的具体计划,但产品依姆多在海外销售。据公开资料显示,新活素与国外的Nesiritide同为适用于急性失代偿心力衰竭治疗的产品。(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071117432095a54e99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071117432095a54e99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600211","BK0239","BK0033"],"gpt_icon":0},{"id":"2450389045","title":"西藏药业07月11日获主力加仓721万元 环比增加390.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450389045","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450389045?lang=zh_cn&edition=full","pubTime":"2024-07-11 15:17","pubTimestamp":1720682225,"startTime":"0","endTime":"0","summary":"07月11日, 西藏药业股价涨2.87%,报收33.28元,成交金额8627万元,换手率0.81%,振幅2.38%,量比1.23。西藏药业今日主力资金净流入721万元,上一交易日主力净流入147万元,今日环比增加390.48%。|07月11日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|金钟股份|9.18%|#|汇成真空|8.72%|#|英可瑞|5.34%|#|热威股份|3.20%|#|神宇股份|3.06%|#|北方铜业|3.04%|#|经纬辉开|2.96%|#|紫天科技|2.80%|#|江南奕帆|2.42%|#|永达股份|2.07%|西藏药业所在的生物制品行业,今日主力净流入1.99亿元,行业排名29/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407111517179f32bb41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407111517179f32bb41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0033","600211","BK0239"],"gpt_icon":0},{"id":"2450989985","title":"西藏药业:\n公司目前暂未收到控股股东回购股票计划。","url":"https://stock-news.laohu8.com/highlight/detail?id=2450989985","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450989985?lang=zh_cn&edition=full","pubTime":"2024-07-10 20:01","pubTimestamp":1720612864,"startTime":"0","endTime":"0","summary":"证券之星消息,西藏药业07月10日在投资者关系平台上答复投资者关心的问题。感谢您对公司的关注。公司目前暂未收到控股股东回购股票计划。公司目前生产经营活动正常,未发生重大变化;除公司已披露的事项外,公司不存在应披露而未披露的重大信息。公司将一如既往地专注主营业务发展,不断提高核心竞争力,提升公司业绩回报广大投资者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000042342.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600211","BK0033","BK0239"],"gpt_icon":0},{"id":"2450885921","title":"西藏药业(600211.SH):新活素新产线预计下半年通过注册审批后投入正式生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2450885921","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450885921?lang=zh_cn&edition=full","pubTime":"2024-07-10 08:42","pubTimestamp":1720572143,"startTime":"0","endTime":"0","summary":"格隆汇7月10日丨西藏药业(600211.SH)披露投资者关系活动记录表显示,新活素新产线预计下半年通过注册审批后投入正式生产,投产后总产能将达到1500万支/年。该生产线总投资约1.4亿,公司将根据会计准则规定及实际情况,预计明年完成转固,转固后分12年折旧或摊销,对公司利润不会产生较大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710084232959ac1b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710084232959ac1b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600211","BK0033","BK0239"],"gpt_icon":0},{"id":"2450000655","title":"【机构调研记录】鹏华基金调研西藏药业、和而泰","url":"https://stock-news.laohu8.com/highlight/detail?id=2450000655","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450000655?lang=zh_cn&edition=full","pubTime":"2024-07-10 08:02","pubTimestamp":1720569724,"startTime":"0","endTime":"0","summary":"鹏华基金成立于1998年,截至目前,资产管理规模8800.78亿元,排名9/204;资产管理规模4278.96亿元,排名10/204;管理公募基金数526只,排名10/204;旗下公募基金经理79人,排名9/204。旗下最近一年表现最佳的公募基金产品为鹏华港美互联股票美元现汇,最新单位净值为0.17,近一年增长29.36%。旗下最新募集公募基金产品为鹏华中证港股通科技ETF发起式联接A,类型为指数型-股票,集中认购期2024年7月8日至2024年7月12日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000012953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0026","BK0070","BK0214","600211","002402","BK0239","BK0033","BK0050","BK0067"],"gpt_icon":0},{"id":"2450005310","title":"【机构调研记录】湘财基金调研西藏药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2450005310","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450005310?lang=zh_cn&edition=full","pubTime":"2024-07-10 08:01","pubTimestamp":1720569715,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及7月9日披露的机构调研信息,湘财基金近期对1家上市公司进行了调研,相关名单如下:1)西藏药业 个股亮点:公司拥有国家一类新药冻干重组人脑利钠肽湘财基金成立于2018年,截至目前,资产管理规模36.54亿元,排名160/204;资产管理规模36.54亿元,排名144/204;管理公募基金数33只,排名119/204;旗下公募基金经理9人,排名117/204。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000012937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","600211","BK0239"],"gpt_icon":0},{"id":"2450599000","title":"【机构调研记录】汇添富基金调研西藏药业、北方国际等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2450599000","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450599000?lang=zh_cn&edition=full","pubTime":"2024-07-10 08:01","pubTimestamp":1720569710,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及7月9日披露的机构调研信息,汇添富基金近期对3家上市公司进行了调研,相关名单如下:1)西藏药业 个股亮点:公司拥有国家一类新药冻干重组人脑利钠肽2)北方国际 个股亮点:公司为中特估概念股。;公司战略调整的目标是通过实施轨道交通、电力等重大国际工程项目,培育公司在轨道交通、电力等领域的专业优势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000012926.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000065","BK0277","BK0033","BK0010","BK0239","BK0186","600211","BK0000"],"gpt_icon":0},{"id":"2450400065","title":"【机构调研记录】中银基金调研西藏药业、荣昌生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2450400065","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450400065?lang=zh_cn&edition=full","pubTime":"2024-07-10 08:01","pubTimestamp":1720569673,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及7月9日披露的机构调研信息,中银基金近期对2家上市公司进行了调研,相关名单如下:1)西藏药业 个股亮点:公司拥有国家一类新药冻干重组人脑利钠肽2)荣昌生物 个股亮点:H股:荣昌生物于2020-11-09上市中银基金成立于2004年,截至目前,资产管理规模5201.41亿元,排名19/204;资产管理规模2829.45亿元,排名17/204;管理公募基金数271只,排名22/204;旗下公募基金经理46人,排名20/204。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000012864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600211","LU1064131003.USD","09995","LU2148510915.USD","BK1161","LU1969619763.USD","BK1574","LU1064130708.USD","LU2328871848.SGD","688331","BK0239","BK0033","BK1583"],"gpt_icon":0},{"id":"2450005130","title":"【机构调研记录】中航基金调研西藏药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2450005130","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450005130?lang=zh_cn&edition=full","pubTime":"2024-07-10 08:01","pubTimestamp":1720569670,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及7月9日披露的机构调研信息,中航基金近期对1家上市公司进行了调研,相关名单如下:1)西藏药业 个股亮点:公司拥有国家一类新药冻干重组人脑利钠肽中航基金成立于2016年,截至目前,资产管理规模318.19亿元,排名100/204;资产管理规模318.19亿元,排名86/204;管理公募基金数45只,排名103/204;旗下公募基金经理16人,排名82/204。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000012861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600211","BK0239","BK0033"],"gpt_icon":0},{"id":"2450013853","title":"西藏药业:雪山金罗汉止痛涂膜剂规格有20ml、30ml、60ml,其中20ml、30ml为新包装","url":"https://stock-news.laohu8.com/highlight/detail?id=2450013853","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450013853?lang=zh_cn&edition=full","pubTime":"2024-07-09 16:53","pubTimestamp":1720515200,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:你好,董秘,请问雪山金罗汉止痛涂膜剂换包装了吗,都是什么规格的,市场上的规格很多分不清,60ml一盒终端的销售价格是多少西藏药业(600211.SH)7月9日在投资者互动平台表示,雪山金罗汉止痛涂膜剂规格有20ml、30ml、60ml,其中20ml、30ml为新包装。60ml在医疗机构销售,属于医保范畴,具体的销售价格请咨询当地医疗机构。(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407091653399f24580d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407091653399f24580d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600211","BK0033","BK0239"],"gpt_icon":0},{"id":"2450609554","title":"西藏药业07月09日主力资金流出43万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2450609554","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450609554?lang=zh_cn&edition=full","pubTime":"2024-07-09 15:17","pubTimestamp":1720509440,"startTime":"0","endTime":"0","summary":"07月09日, 西藏药业股价涨0.98%,报收32.01元,成交金额6639万元,换手率0.65%,振幅2.81%,量比1.12。西藏药业今日主力资金净流出43万元,连续5日净流出,上一交易日主力净流出80万元,今日环比减少46.25%。该股近5个交易日下跌3.03%,主力资金累计净流出809万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出8037万元,其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070915182295957f1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070915182295957f1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0033","BK0239","600211"],"gpt_icon":0},{"id":"2449634232","title":"西藏药业07月05日主力资金流出109万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2449634232","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449634232?lang=zh_cn&edition=full","pubTime":"2024-07-05 15:17","pubTimestamp":1720163825,"startTime":"0","endTime":"0","summary":"07月05日, 西藏药业股价涨2.21%,报收32.83元,成交金额6858万元,换手率0.66%,振幅3.11%,量比1.10。西藏药业今日主力资金净流出109万元,连续3日净流出,上一交易日主力净流出350万元,今日环比减少68.86%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为75.00%,平均跌幅为1.44%。该股近5个交易日上涨0.77%,主力资金累计净流出307万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出9345万元,其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407051517319f08cee8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407051517319f08cee8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0033","600211"],"gpt_icon":0},{"id":"2449008564","title":"西藏板块盘中跳水,西藏药业跌0.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449008564","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449008564?lang=zh_cn&edition=full","pubTime":"2024-07-05 09:39","pubTimestamp":1720143557,"startTime":"0","endTime":"0","summary":"07月05日,西藏板块盘中跳水,截至09点39分,西藏板块整体指数下跌0.53%,报1388.080点。从个股上来看,该板块的成分股中,西藏药业跌0.47%,易明医药、多瑞医药、奇正藏药跌幅居前。从资金上来看,截止发稿,西藏板块主力净流入为-2843.00万,其中西藏城投受到资金热捧,主力净流入1289.26万;拉长时间线来看,该板块近20日主力资金净流入-10.78亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705093917af90a62d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705093917af90a62d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0033","600211"],"gpt_icon":0},{"id":"2448661064","title":"脑科学(脑机接口)概念盘中跳水,西藏药业跌0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448661064","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448661064?lang=zh_cn&edition=full","pubTime":"2024-07-04 09:41","pubTimestamp":1720057271,"startTime":"0","endTime":"0","summary":"07月04日,脑科学(脑机接口)概念盘中跳水,截至09点41分,脑科学(脑机接口)概念整体指数下跌0.50%,报535.570点。从个股上来看,该概念的成分股中,西藏药业跌0.12%,成都华微跌幅居前。从资金上来看,截止发稿,脑科学(脑机接口)概念主力净流入为-989.63万,其中均胜电子受到资金热捧,主力净流入513.01万;拉长时间线来看,该板块近20日主力资金净流入-35.62亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704094111aef7db7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704094111aef7db7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0033","600211","BK0239"],"gpt_icon":0},{"id":"2448139856","title":"西藏药业:公司会根据中药的原材料价格、生产成本上涨等实际情况进行相应调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2448139856","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448139856?lang=zh_cn&edition=full","pubTime":"2024-07-02 18:02","pubTimestamp":1719914528,"startTime":"0","endTime":"0","summary":"证券之星消息,西藏药业(600211)07月02日在投资者关系平台上答复投资者关心的问题。投资者:中药都在涨价,你们咋不涨价?西藏药业董秘:您好!感谢您对公司的关注。公司会根据中药的原材料价格、生产成本上涨等实际情况进行相应调整。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407021803429565bd03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407021803429565bd03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0033","600211"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1999-07-21","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区A区广州路3号","stockEarnings":[{"period":"1week","weight":-0.0587},{"period":"1month","weight":-0.0252},{"period":"3month","weight":-0.1346},{"period":"6month","weight":0.0647},{"period":"1year","weight":-0.2134},{"period":"ytd","weight":-0.1406}],"companyName":"西藏诺迪康药业股份有限公司","boardCode":"AI0027","perCapita":"7769股","boardName":"医药制造业","registeredCapital":"32231万元","compareEarnings":[{"period":"1week","weight":-0.0244},{"period":"1month","weight":-0.0255},{"period":"3month","weight":-0.0686},{"period":"6month","weight":0.037},{"period":"1year","weight":-0.1172},{"period":"ytd","weight":-0.0279}],"survey":" 西藏诺迪康药业股份有限公司主要业务是生产、销售胶囊剂、生物制剂、颗粒剂、涂膜剂等。公司主要产品涉及心脑血管、肝胆、扭挫伤及风湿、类风湿、感冒等领域,代表品种有新活素、依姆多、诺迪康、十味蒂达胶囊、雪山金罗汉止痛涂膜剂、小儿双清颗粒等。公司先后荣获“金牛最具投资价值奖”“生物医药最具成长上市公司”“中国中药工业百强企业TOP100”“中国医药工业百强企业”“西藏自治区专精特新中小企业”“西藏自治区民营企业20强”等多项荣誉。西藏自治区药品监督管理局向我公司授予“药品标准科研基地”。","serverTime":1722288348562,"listedPrice":6,"stockholders":"41484人(较上一季度增加0.25%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"西藏药业(600211)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供西藏药业(600211)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"西藏药业,600211,西藏药业股票,西藏药业股票老虎,西藏药业股票老虎国际,西藏药业行情,西藏药业股票行情,西藏药业股价,西藏药业股市,西藏药业股票价格,西藏药业股票交易,西藏药业股票购买,西藏药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"西藏药业(600211)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供西藏药业(600211)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}